Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

Adil Vural, MD, & Kinanah Yaseen, MD  |  Issue: May 2023  |  May 9, 2023

This case highlights the importance of adding AAV to potential causes of migratory polyarthritis and a false positive RF test because early recognition is vital. Screening for renal disease by obtaining a routine urinalysis is important in patients with AAV because early renal involvement is typically asymptomatic.


Adil Vural, MD, is a third-year internal medicine resident at Cleveland Clinic Fairview Hospital. He is going to start a rheumatology fellowship at Cleveland Clinic after his graduation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Kinanah Yaseen, MD, is a staff rheumatologist at Cleveland Clinic. She completed her rheumatology fellowship, then a vasculitis fellowship at Cleveland Clinic.

References

  1. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992 Mar 15;116(6):488–498.
  2. Kitching AR, Anders HJ, Basu N, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020 Aug 27;6(1):71.
  3. Ruddy S, Harris ED, Sledge CB, et al. Kelley’s Textbook of Rheumatology (sixth ed.) Philadelphia: W.B. Saunders; 2001.
  4. Koskinen E, Hannonen P, Sokka T. Palindromic rheumatism: Long-term outcomes of 60 patients diagnosed in 1967–1984. J Rheumatol. 2009 Sep;36:1873–1875.
  5. Katz SJ, Russell AS. Palindromic rheumatism: A pre-rheumatoid arthritis state? J Rheumatol. 2012 Oct;39:1912–1913.
  6. Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol. 2000 Jul;12(4):289–294.
  7. Inman RD. Rheumatic manifestations of hepatitis B virus infection. Semin Arthritis Rheum. 1982 May;11(4):406–420.
  8. Moro ML, Grilli E, Corvetta A, et al. Long-term chikungunya infection clinical manifestations after an outbreak in Italy: A prognostic cohort study. J Infect. 2012 Aug;65(2):165–172.
  9. Glaser C, Rieg S, Wiech T, et al. Whipple’s disease mimicking rheumatoid arthritis can cause misdiagnosis and treatment failure. Orphanet J Rare Dis. 2017 May 25;12(1):99.
  10. Zoma A. Musculoskeletal involvement in systemic lupus erythematosus. Lupus. 2004;13:851–853.
  11. Visser H, Vos K, Zanelli E, et al. Sarcoid arthritis: Clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis. 2002 Jun;61(6):499–504.
  12. Jamilloux Y, Kodjikian L, Broussolle C, et al. Sarcoidosis and uveitis. Autoimmun Rev. 2014 Aug;13(8):840–849.
  13. Zupancic M, Annamalai A, Brenneman J, et al. Migratory polyarthritis as a paraneoplastic syndrome. J Gen Intern Med. 2008 Dec;23(12):2136–2139.
  14. Sreih AG, Cronin K, Shaw DG, et al. Diagnostic delays in vasculitis and factors associated with time to diagnosis. Orphanet J Rare Dis. 2021 Apr 21;16(1):184.
  15. Moon JS, Lee DDH, Park YB, et al. Rheumatoid factor false positivity in patients with ANCA-associated vasculitis not having medical conditions producing rheumatoid factor. Clin Rheumatol. 2018 Oct;37(10):2771–2779.
  16. Zhao X, Wen Q, Qiu Y, Huang F. Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis. Rheumatol Int. 2021 Feb;41(2):455–462.
  17. Ingegnoli F, Castelli R, Gualtierotti R. Rheumatoid factors: Clinical applications. Dis Markers. 2013;35:727–734.
  18. Hagen EC, Daha MR, Hermans JO, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 1998 Mar;53(3):743–753.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitiscase reportGranulomatosisgranulomatosis with polyangiitismigratory polyarthritis

Related Articles

    ANCA-Associated Vasculitis Trial Results May Change Standard of Care

    May 15, 2020

    SNOWMASS VILLAGE, COLO.—The study of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is ongoing, and research results should help improve treatment for this patient pop­ulation. Key trials and therapeutic options were discussed at the 2020 ACR Winter Symposium during the session, Update on the Treatment of ANCA-Associated Vasculitis, by Peter A. Merkel, MD, MPH, chief of…

    Mortality from Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Falling Slightly

    October 9, 2019

    NEW YORK (Reuters Health)—Mortality rates in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) decreased from 1999 to 2017, according to records from the Centers for Disease Control and Prevention (CDC). “The mortality attributed to several rare diseases [e.g., hypersensitivity pneumonitis] has increased in recent years,” Alexander W. Steinberg, MD, from Saint Joseph Hospital, Denver, tells…

    Trimethoprim-Sulfamethoxazole Prophylaxis Reduced Rituximab Infection Risk

    October 18, 2018

    Severe infections occurred in 25% of patients with anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) who were treated with rituximab, according to results of an observational study conducted in the United Kingdom (U.K.) and Austria. Trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis, however, reduced the risk of severe infections, the investigators reported in Annals of the Rheumatic Diseases.1 Andreas…

    ANCA Mortality: Are Patients Doing Better?

    December 13, 2019

    Patients with anti-neutrophil cytoplasmic antibody–associated vasculitides (AAV) have an increased risk of mortality. But treatments have evolved in recent years. Recent research found that between 1999 and 2017 the AAV mortality rate declined by nearly 2% per year in patients 65–74 years old…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences